|
1
|
Gasparini C, Celeghini C, Monasta L and
Zauli G: NF-κB pathways in hematological malignancies. Cell Mol
Life Sci. 71:2083–2102. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Carbone A, Tripodo C, Carlo-Stella C,
Santoro A and Gloghini A: The role of inflammation in lymphoma. Adv
Exp Med Biol. 816:315–333. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hoesel B and Schmid JA: The complexity of
NF-κB signaling in inflammation and cancer. Mol Cancer. 12:862013.
View Article : Google Scholar
|
|
4
|
Horie R and Watanabe T: The biological
basis of Hodgkin's lymphoma. Drug News Perspect. 16:649–656. 2003.
View Article : Google Scholar
|
|
5
|
Vockerodt M, Yap L-F, Shannon-Lowe C,
Curley H, Wei W, Vrzalikova K and Murray PG: The Epstein-Barr virus
and the pathogenesis of lymphoma. J Pathol. 235:312–322. 2015.
View Article : Google Scholar
|
|
6
|
Kaye KM, Izumi KM and Kieff E:
Epstein-Barr virus latent membrane protein 1 is essential for
B-lymphocyte growth transformation. Proc Natl Acad Sci USA.
90:9150–9154. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Devergne O, Cahir McFarland ED, Mosialos
G, Izumi KM, Ware CF and Kieff E: Role of the TRAF binding site and
NF-kappaB activation in Epstein-Barr virus latent membrane protein
1-induced cell gene expression. J Virol. 72:7900–7908.
1998.PubMed/NCBI
|
|
8
|
Izumi KM and Kieff ED: The Epstein-Barr
virus oncogene product latent membrane protein 1 engages the tumor
necrosis factor receptor-associated death domain protein to mediate
B lymphocyte growth transformation and activate NF-kappaB. Proc
Natl Acad Sci USA. 94:12592–12597. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Schultheiss U, Püschner S, Kremmer E, Mak
TW, Engelmann H, Hammerschmidt W and Kieser A: TRAF6 is a critical
mediator of signal transduction by the viral oncogene latent
membrane protein 1. EMBO J. 20:5678–5691. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Soni V, Cahir-McFarland E and Kieff E:
LMP1 TRAFficking activates growth and survival pathways. Adv Exp
Med Biol. 597:173–187. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Horie R, Watanabe T, Morishita Y, Ito K,
Ishida T, Kanegae Y, Saito I, Higashihara M, Mori S, Kadin ME, et
al: Ligand-independent signaling by overexpressed CD30 drives
NF-kappaB activation in Hodgkin-Reed-Sternberg cells. Oncogene.
21:2493–2503. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Horie R, Aizawa S, Nagai M, Ito K,
Higashihara M, Ishida T, Inoue J and Watanabe T: A novel domain in
the CD30 cytoplasmic tail mediates NFkappaB activation. Int
Immunol. 10:203–210. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Arkan MC and Greten FR: IKK- and
NF-κB-mediated functions in carcinogenesis. Curr Top Microbiol
Immunol. 349:159–169. 2011.
|
|
14
|
Ryan KM, Ernst MK, Rice NR and Vousden KH:
Role of NF-kappaB in p53-mediated programmed cell death. Nature.
404:892–897. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sheehy AM and Schlissel MS: Overexpression
of RelA causes G1 arrest and apoptosis in a pro-B cell line. J Biol
Chem. 274:8708–8716. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kuilman T, Michaloglou C, Mooi WJ and
Peeper DS: The essence of senescence. Genes Dev. 24:2463–2479.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Schmitt CA: Cellular senescence and cancer
treatment. Biochim Biophys Acta. 1775:5–20. 2007.
|
|
18
|
Jing H and Lee S: NF-κB in cellular
senescence and cancer treatment. Mol Cells. 37:189–195. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yamazaki S, Muta T and Takeshige K: A
novel IkappaB protein, IkappaB-zeta, induced by proinflammatory
stimuli, negatively regulates nuclear factor-kappaB in the nuclei.
J Biol Chem. 276:27657–27662. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Muta T: IkappaB-zeta: An inducible
regulator of nuclear factor-kappaB. Vitam Horm. 74:301–316. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yamamoto M, Yamazaki S, Uematsu S, Sato S,
Hemmi H, Hoshino K, Kaisho T, Kuwata H, Takeuchi O, Takeshige K, et
al: Regulation of Toll/IL-1-receptor-mediated gene expression by
the inducible nuclear protein IkappaBzeta. Nature. 430:218–222.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Nogai H, Wenzel S-S, Hailfinger S, Grau M,
Kaergel E, Seitz V, Wollert-Wulf B, Pfeifer M, Wolf A, Frick M, et
al: IκB-ζ controls the constitutive NF-κB target gene network and
survival of ABC DLBCL. Blood. 122:2242–2250. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kimura R, Senba M, Cutler SJ, Ralph SJ,
Xiao G and Mori N: Human T cell leukemia virus type I tax-induced
IκB-ζ modulates tax-dependent and tax-independent gene expression
in T cells. Neoplasia. 15:1110–1124. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Floettmann JE and Rowe M: Epstein-Barr
virus latent membrane protein-1 (LMP1) C-terminus activation region
2 (CTAR2) maps to the far C-terminus and requires oligomerisation
for NF-kappaB activation. Oncogene. 15:1851–1858. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huen DS, Henderson SA, Croom-Carter D and
Rowe M: The Epstein-Barr virus latent membrane protein-1 (LMP1)
mediates activation of NF-kappa B and cell surface phenotype via
two effector regions in its carboxy-terminal cytoplasmic domain.
Oncogene. 10:549–560. 1995.PubMed/NCBI
|
|
26
|
Julien S, Puig I, Caretti E, Bonaventure
J, Nelles L, van Roy F, Dargemont C, de Herreros AG, Bellacosa A
and Larue L: Activation of NF-kappaB by Akt upregulates Snail
expression and induces epithelium mesenchyme transition. Oncogene.
26:7445–7456. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Motoyama M, Yamazaki S, Eto-Kimura A,
Takeshige K and Muta T: Positive and negative regulation of nuclear
factor-kappaB-mediated transcription by IkappaB-zeta, an inducible
nuclear protein. J Biol Chem. 280:7444–7451. 2005. View Article : Google Scholar
|
|
28
|
Brockman JA, Scherer DC, McKinsey TA, Hall
SM, Qi X, Lee WY and Ballard DW: Coupling of a signal response
domain in I kappa B alpha to multiple pathways for NF-kappa B
activation. Mol Cell Biol. 15:2809–2818. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Geleziunas R, Ferrell S, Lin X, Mu Y,
Cunningham ET Jr, Grant M, Connelly MA, Hambor JE, Marcu KB and
Greene WC: Human T-cell leukemia virus type 1 Tax induction of
NF-kappaB involves activation of the IkappaB kinase alpha
(IKKalpha) and IKKbeta cellular kinases. Mol Cell Biol.
18:5157–5165. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Iha H, Kibler KV, Yedavalli VRK,
Peloponese JM, Haller K, Miyazato A, Kasai T and Jeang K-T:
Segregation of NF-kappaB activation through NEMO/IKKgamma by Tax
and TNFalpha: Implications for stimulus-specific interruption of
oncogenic signaling. Oncogene. 22:8912–8923. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
McKinsey TA, Brockman JA, Scherer DC,
Al-Murrani SW, Green PL and Ballard DW: Inactivation of IkappaBbeta
by the tax protein of human T-cell leukemia virus type 1: A
potential mechanism for constitutive induction of NF-kappaB. Mol
Cell Biol. 16:2083–2090. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Aizawa S, Nakano H, Ishida T, Horie R,
Nagai M, Ito K, Yagita H, Okumura K, Inoue J and Watanabe T: Tumor
necrosis factor receptor-associated factor (TRAF) 5 and TRAF2 are
involved in CD30-mediated NFkappaB activation. J Biol Chem.
272:2042–2045. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yamazaki S, Muta T, Matsuo S and Takeshige
K: Stimulus-specific induction of a novel nuclear factor-kappaB
regulator, IkappaB-zeta, via Toll/Interleukin-1 receptor is
mediated by mRNA stabilization. J Biol Chem. 280:1678–1687. 2005.
View Article : Google Scholar
|
|
34
|
Suzuki T, Hirai H, Murakami T and Yoshida
M: Tax protein of HTLV-1 destabilizes the complexes of NF-kappa B
and I kappa B-alpha and induces nuclear translocation of NF-kappa B
for transcriptional activation. Oncogene. 10:1199–1207.
1995.PubMed/NCBI
|
|
35
|
Okamoto S, Mukaida N, Yasumoto K, Rice N,
Ishikawa Y, Horiguchi H, Murakami S and Matsushima K: The
interleukin-8 AP-1 and kappa B-like sites are genetic end targets
of FK506-sensitive pathway accompanied by calcium mobilization. J
Biol Chem. 269:8582–8589. 1994.PubMed/NCBI
|
|
36
|
Shimizu H, Mitomo K, Watanabe T, Okamoto S
and Yamamoto K: Involvement of a NF-kappa B-like transcription
factor in the activation of the interleukin-6 gene by inflammatory
lymphokines. Mol Cell Biol. 10:561–568. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ge B, Li O, Wilder P, Rizzino A and
McKeithan TW: NF-kappa B regulates BCL3 transcription in T
lymphocytes through an intronic enhancer. J Immunol. 171:4210–4218.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Mori N and Prager D: Transactivation of
the interleukin-1alpha promoter by human T-cell leukemia virus type
I and type II Tax proteins. Blood. 87:3410–3417. 1996.PubMed/NCBI
|
|
39
|
Horie R and Watanabe T, Ito K, Morisita Y,
Watanabe M, Ishida T, Higashihara M, Kadin M and Watanabe T:
Cytoplasmic aggregation of TRAF2 and TRAF5 proteins in the
Hodgkin-Reed-Sternberg cells. Am J Pathol. 160:1647–1654. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sylla BS, Hung SC, Davidson DM,
Hatzivassiliou E, Malinin NL, Wallach D, Gilmore TD, Kieff E and
Mosialos G: Epstein-Barr virus-transforming protein latent
infection membrane protein 1 activates transcription factor
NF-kappaB through a pathway that includes the NF-kappaB-inducing
kinase and the IkappaB kinases IKKalpha and IKKbeta. Proc Natl Acad
Sci USA. 95:10106–10111. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hayden MS and Ghosh S: Shared principles
in NF-kappaB signaling. Cell. 132:344–362. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Canoz O, Rassidakis GZ, Admirand JH and
Medeiros LJ: Immunohistochemical detection of BCL-3 in lymphoid
neoplasms: A survey of 353 cases. Mod Pathol. 17:911–917. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Palmer S and Chen YH: Bcl-3, a
multifaceted modulator of NF-kappaB-mediated gene transcription.
Immunol Res. 42:210–218. 2008. View Article : Google Scholar : PubMed/NCBI
|
